LOBULAR BREAST CARCINOMA IN SITU
Clinical trials for LOBULAR BREAST CARCINOMA IN SITU explained in plain language.
Never miss a new study
Get alerted when new LOBULAR BREAST CARCINOMA IN SITU trials appear
Sign up with your email to follow new studies for LOBULAR BREAST CARCINOMA IN SITU, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New radiation schedule aims to cut breast cancer side effects
Disease control OngoingThis study tested a shorter course of radiation (hypofractionation) for women with breast cancer that has spread to lymph nodes. The goal was to see if this approach reduces long-term side effects like arm swelling (lymphedema) while still controlling cancer. About 137 women part…
Matched conditions: LOBULAR BREAST CARCINOMA IN SITU
Phase: NA • Sponsor: Virginia Commonwealth University • Aim: Disease control
Last updated May 26, 2026 03:14 UTC
-
Diabetes drug metformin tested as breast cancer shield in High-Risk women
Prevention OngoingThis study tested whether taking metformin (a common diabetes drug) for 12 months could reduce abnormal breast cell growth in women at high risk for breast cancer. The 86 participants had prior breast abnormalities or strong family history. Researchers compared metformin to a pla…
Matched conditions: LOBULAR BREAST CARCINOMA IN SITU
Phase: PHASE3 • Sponsor: Alliance for Clinical Trials in Oncology • Aim: Prevention
Last updated May 22, 2026 14:03 UTC
-
Web tools aim to empower women facing tough breast cancer prevention decisions
Knowledge-focused OngoingThis study looks at whether online decision-support tools help women with atypical hyperplasia or lobular carcinoma in situ (conditions that raise breast cancer risk) make informed choices about taking chemoprevention drugs. About 412 women and their doctors will use these tools.…
Matched conditions: LOBULAR BREAST CARCINOMA IN SITU
Phase: NA • Sponsor: SWOG Cancer Research Network • Aim: Knowledge-focused
Last updated May 26, 2026 03:10 UTC